Your Health, We Care
WhatsApp:
Dosage form:Tablet
Specs:40mg*90 Tablets
Indate:48 months
Gilteritinib, as a FLT3 inhibitor, has demonstrated significant clinical activity in patients with FLT3-mutated (FLT3mut) relapsed/refractory (R/R) acute myeloid leukemia (AML). To···【more】
Article source：Lucius LaosRelease date：2024-11-22Recommended：360
Gireltinib is primarily effective in acute myeloid leukemia (AML), particularly in relapsed or refractory AML harboring FLT3 mutations.InhibitionGireltinib is a novel, highly selec···【more】
Article source：Lucius LaosRelease date：2024-11-21Recommended：344
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
